Clinical Trials Logo

Filter by:
NCT ID: NCT05967182 Recruiting - Cholangiocarcinoma Clinical Trials

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Start date: January 16, 2024
Phase: Phase 2
Study type: Interventional

To find out if adding pembrolizumab to standard of care chemotherapy drugs (cisplatin and gemcitabine) will improve long-term response of intrahepatic cholangiocarcinoma after surgery, compared to treatment with surgery and standard chemotherapy alone.

NCT ID: NCT05966883 Recruiting - Male Infertility Clinical Trials

SpermQT Prospective Observational Trial

SPOT
Start date: January 1, 2023
Phase:
Study type: Observational

The goal of the study is to validate the ability of the Epigenetic Sperm Quality Test (SpermQT) to assess a man's sperm quality and corresponding success of infertility treatments.

NCT ID: NCT05966870 Completed - PreDiabetes Clinical Trials

Unsweetened Sparkling Water and Changes in Sweetness Perception in Adolescents

Start date: March 9, 2020
Phase: N/A
Study type: Interventional

The study design is a prospective observational study in adolescents who are at risk for developing Type 2 Diabetes (T2D), to evaluate the effectiveness of sparkling water to reduce dietary intake of added sugars and thereby improve glycemia. Study data on consumption and the flavor profile of sparkling water will serve as a measure of acceptability. The study intervention will be to provide carbonated flavored sparkling water for 12 weeks to adolescents (and their families) who have a usual intake of 2 or more servings of sugar sweetened beverages (SSB) per day and are at a high risk for developing type 2 diabetes. Study measures will be obtained before and after the exposure to carbonated flavored sparkling water and each participant will serve as his/her own control. To encourage the participants to substitute the carbonated flavored sparkling water, study personnel will send them weekly iMessages through the Technology Assisted Dietary Assessment (TADA) app. In addition, investigators will monitor the participants' diet, using the TADA app, every two weeks, for 4 days. Study measurements will be obtained at baseline, before the intervention, during and at the end of the 12 week intervention. Objective: Determine the effect of reducing added sugars intake by substituting carbonated sparkling water on T2D risk in adolescents. Hypothesis: Adolescents who decrease consumption of SSB by substituting sparkling water will experience decreased blood glucose concentrations and increased insulin sensitivity during an oral glucose tolerance test and decreased glucose excursions during continued glucose monitoring, compared to those who do not decrease consumption of SSB.

NCT ID: NCT05966831 Enrolling by invitation - Self-Control Clinical Trials

Metacognitive Self Control and Job Interview Training

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The study is a randomized controlled trial (RCT) that assesses the effectiveness of a metacognitive self-control training intervention (MCT) in conjunction with virtual-reality job interview training (VR-JIT) in a sample of formerly incarcerated individuals. The study also includes an implementation evaluation.

NCT ID: NCT05966805 Recruiting - Clinical trials for Psychological Wellness

Impact of Exercise Intervention on Well-being in Shift-working Acute Care Nurses

WELL_NURSE
Start date: September 13, 2023
Phase: N/A
Study type: Interventional

This is a randomized, wait-list control pilot study to analyze the impact of a 12-week exercise training intervention on post-traumatic growth and whole-person well-being (mental health, physical health, spiritual well-being, perceived social support, and occupational health) among shift-working acute care nurses within AdventHealth.

NCT ID: NCT05966766 Completed - Anxiety Clinical Trials

Dosing Music for Anxiety Reduction in Parturients

Start date: December 7, 2023
Phase: N/A
Study type: Interventional

This is a clinical study that aims to determine the effective dose of music listening duration that is required to reduce anxiety in patients awaiting scheduled cesarean section. It will also compare types of music to accomplish this goal, both of which have been shown effective in prior studies. Methods will involve enrolling and playing music for patients awaiting scheduled C-section, and scoring their anxiety with pre- and post-music questionnaires. Music duration for each subject will be predetermined, and analysis of response will be performed to determine the effective dose 95%, or dose at which 95% of subjects should have a positive response.

NCT ID: NCT05966753 Completed - Clinical trials for Diabetic Macular Edema

Describing Patient With DME, Their Patient Journey and Disease Progression

Start date: August 3, 2023
Phase:
Study type: Observational

This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.

NCT ID: NCT05966740 Recruiting - Clinical trials for Venous Thromboembolism

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Start date: October 31, 2023
Phase:
Study type: Observational

The main research question of this study is to obtain further safety and effectiveness data on Pradaxa Pellets in children aged 3 months to less than 12 years in routine clinical practice setting.

NCT ID: NCT05966688 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants

Start date: August 4, 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to evaluate the pharmacokinetics (PK) of SPR720, azithromycin, and ethambutol, administered separately and co-administered, in healthy adult participants.

NCT ID: NCT05966662 Recruiting - Clinical trials for Coronary Artery Disease

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Start date: December 8, 2023
Phase: N/A
Study type: Interventional

This investigational device exemption (IDE) study is to assess the safety and effectiveness of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2+ 2Hz Coronary IVL Catheter to treat de novo, calcified, stenotic, coronary lesions prior to stenting.